A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties (Q24309030)

GOA release 2020-03-11

drug binding

1 reference

GOA release 2020-03-11

author name string

Neil Moss

1

0 references

Younggi Choi

2

0 references

Derek Cogan

3

0 references

Adam Flegg

4

0 references

Andreas Kahrs

5

0 references

Pui Loke

6

0 references

Orietta Meyn

7

0 references

Raj Nagaraja

8

0 references

Spencer Napier

9

0 references

Ashley Parker

10

0 references

J Thomas Peterson

11

0 references

Philip Ramsden

12

0 references

Christopher Sarko

13

0 references

Donna Skow

14

0 references

Josh Tomlinson

15

0 references

Heather Tye

16

0 references

Mark Whitaker

Bioorganic & Medicinal Chemistry Letters

17

0 references

language of work or name

English

0 references

publication date

15 April 2009

0 references

published in

0 references

volume

19

0 references

issue

8

0 references

page(s)

2206-10

0 references

cites work

A simple method for predicting serum protein binding of compounds from IC(50) shift analysis for in vitro assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-kappaB in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

Functions of serotonin in hypoxic pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

The importance of plasma protein binding in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021

The Emergence of Selective 5-HT2B Antagonists Structures, Activities and Potential Therapeutic Applications [General Reviews]

1 reference

https://api.crossref.org/works/10.1016%2FJ.BMCL.2009.02.126

7 January 2021